1. Home
  2. RYTM vs SHC Comparison

RYTM vs SHC Comparison

Compare RYTM & SHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • SHC
  • Stock Information
  • Founded
  • RYTM 2008
  • SHC 2015
  • Country
  • RYTM United States
  • SHC United States
  • Employees
  • RYTM N/A
  • SHC N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • SHC Medical Specialities
  • Sector
  • RYTM Health Care
  • SHC Health Care
  • Exchange
  • RYTM Nasdaq
  • SHC Nasdaq
  • Market Cap
  • RYTM 3.1B
  • SHC 3.6B
  • IPO Year
  • RYTM 2017
  • SHC 2020
  • Fundamental
  • Price
  • RYTM $57.07
  • SHC $13.62
  • Analyst Decision
  • RYTM Strong Buy
  • SHC Buy
  • Analyst Count
  • RYTM 10
  • SHC 6
  • Target Price
  • RYTM $66.90
  • SHC $16.50
  • AVG Volume (30 Days)
  • RYTM 549.1K
  • SHC 958.3K
  • Earning Date
  • RYTM 02-20-2025
  • SHC 02-25-2025
  • Dividend Yield
  • RYTM N/A
  • SHC N/A
  • EPS Growth
  • RYTM N/A
  • SHC N/A
  • EPS
  • RYTM N/A
  • SHC 0.25
  • Revenue
  • RYTM $112,530,000.00
  • SHC $1,120,477,000.00
  • Revenue This Year
  • RYTM $63.77
  • SHC $5.88
  • Revenue Next Year
  • RYTM $44.91
  • SHC $5.40
  • P/E Ratio
  • RYTM N/A
  • SHC $53.43
  • Revenue Growth
  • RYTM 81.55
  • SHC 13.11
  • 52 Week Low
  • RYTM $35.17
  • SHC $10.71
  • 52 Week High
  • RYTM $68.58
  • SHC $17.44
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 52.43
  • SHC 53.32
  • Support Level
  • RYTM $52.71
  • SHC $12.24
  • Resistance Level
  • RYTM $60.12
  • SHC $13.52
  • Average True Range (ATR)
  • RYTM 2.11
  • SHC 0.43
  • MACD
  • RYTM -0.00
  • SHC 0.03
  • Stochastic Oscillator
  • RYTM 58.93
  • SHC 72.70

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in development and commercialization of therapies for patients with rare diseases. It is focused on the development and commercialization of peptide therapeutics for the treatment of gastrointestinal, or GI, diseases, and genetic deficiencies that result in metabolic disorders. The company's product candidate is setmelanotide (RM 493), which is a potent, melanocortin 4, or MC4, receptor agonist for the treatment of rare genetic disorders of obesity caused by MC4 pathway deficiencies. Geographically the company generates its revenue from the United states, Germany, and other with the majority being generated from the United states.

About SHC Sotera Health Company

Sotera Health Co provides sterilization, analytical lab testing, and advisory services to help ensure that medical, pharmaceutical and food products are safe for healthcare practitioners, patients, and consumers. The company operates in three segments: Sterigenics, Nordion, and Nelson Labs. Sterigenics provides outsourced terminal sterilization and irradiation services for medical device, pharmaceutical, food safety, and advanced applications; Nordion provides Co-60 and gamma irradiators, which are the key components to the gamma sterilization process; and Nelson Labs provides outsourced microbiological and analytical chemistry testing for the medical device and pharmaceutical industries. Its geographical segments are the United States, Canada, Europe, and other regions.

Share on Social Networks: